Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A nonrandomized, observational, comparative multicenter cohort study was conducted at 17 European medical centers. Patients treated with ampicillin+ceftriaxone (AC) were generally more ill at baseline than patients treated with ampicillin+gentamicin (AG). Despite this there was no difference in mortality or treatment failure between the groups.

Ampicillin plus Ceftriaxone for Enterococcal Endocarditis